Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation

Published:2016-04 Issue:4 Volume:22 Page:710-716
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Williams Kirsten M.,Cheng Guang-Shing,Pusic Iskra,Jagasia Madan,Burns Linda,Ho Vincent T.,Pidala Joseph,Palmer Jeanne,Johnston Laura,Mayer Sebastian,Chien Jason W.,Jacobsohn David A.,Pavletic Steven Z.,Martin Paul J.,Storer Barry E.,Inamoto Yoshihiro,Chai Xiaoyu,Flowers Mary E.D.,Lee Stephanie J.^ORCID

Funder

NCATS

National Cancer Institute

GlaxoSmithKline

Merck

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference50 articles.

1. Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation;Williams;JAMA,2009

2. Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease;Palmer;Biol Blood Marrow Transplant,2014